drugset / Trial / NCT04008901
The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was conducted to prove the efficacy of BST-104 in patients with mild to moderate FD.
Timeline
- Start
- 2017-02-13
- Primary completion
- 2018-07-02
- Completion
- 2018-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BST104 | Unknown | 175 mg | — |